Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evogene Ltd.EVGN · Entity 8065 | Director | September 04, 2026 | September 30, 2026 |
| KAMADA LTDKMDA · Entity 5493 | Director | August 27, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evogene Ltd.
Report date September 04, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.58 · Expires 2036-09-04 | Direct | 2,500 |
Reported balance
After 2026-09-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-04 · Grant · Acquired 2,500 · Balance 2,500 F2: The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F3: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan, F4: The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $54.32 · Expires 2027-05-16 | Direct | 250 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 250 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.05 · Expires 2028-06-25 | Direct | 250 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 250 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.68 · Expires 2029-07-30 | Direct | 250 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 250 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.03 · Expires 2030-11-17 | Direct | 250 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 250 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.32 · Expires 2031-06-11 | Direct | 250 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 250 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.62 · Expires 2031-09-01 | Direct | 1,800 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 1,800 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.50 · Expires 2032-09-15 | Direct | 1,800 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 1,800 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.03 · Expires 2033-05-11 | Direct | 1,800 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 1,800 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.16 · Expires 2034-06-13 | Direct | 1,800 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 1,800 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.29 · Expires 2035-08-18 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 2,500 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,343,886 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,343,886 F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
Filing footnotes · ownership attribution and instrument terms
F1: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F2: The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date.
F3: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan,
F4: The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date.
KAMADA LTD
Report date August 27, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.41 | IndirectHeld by trustee | 26,500 |
Reported balance
After 2026-08-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-27 · Grant · Acquired 26,500 · Balance 26,500 F1: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3: Held by trustee under the Company's 2011 Share Award Plan. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.99 | IndirectHeld by trustee | 30,000 |
Reported balance
After 2026-08-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-27 · Grant · Acquired 30,000 · Balance 30,000 F1: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3: Held by trustee under the Company's 2011 Share Award Plan. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.38 | IndirectHeld by trustee | 30,000 |
Reported balance
After 2026-08-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-27 · Grant · Acquired 30,000 · Balance 30,000 F1: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F6: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3: Held by trustee under the Company's 2011 Share Award Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
F2: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
F3: Held by trustee under the Company's 2011 Share Award Plan.
F4: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
F5: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
F6: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 30, 2026 08:13 UTC | Evogene Ltd. EVGN · Entity 8065 | GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001178913-26-004664 · ownership.xml · derivative · entry 2 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires 2036-09-04 F2 · derivative.exercise_price: The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date. F3 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan, F4 · derivative.exercise_date: The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date. Read SEC document |
| August 27, 2026 Filed Sep 23, 2026 19:58 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 3 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F6 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 23, 2026 19:58 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.99 | $0.00 |
DisclosureSEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 2 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 27, 2026 Filed Sep 23, 2026 19:58 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 26,500 Underlying: Ordinary Shares · 26,500 shares Expires not disclosed F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026. F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 11:00 UTC | Evogene Ltd. EVGN · Entity 8065 | PurchaseOrdinary Shares | 460,000 | $0.64 | $292,100.00 |
DisclosureSEC source: 0001178913-26-004095 · ownership.xml · nonDerivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,343,886 Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 11:00 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001213900-26-085898 · ownership.xml · derivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:07 UTC | Evogene Ltd. EVGN · Entity 8065 | PurchaseOrdinary Shares | 800,000 | $0.50 | $400,000.00 |
DisclosureSEC source: 0001178913-26-003859 · ownership.xml · nonDerivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,886 F1 · price: The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 16 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 15 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 14 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 13 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 12 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 11 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.48 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 10 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.23 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 9 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $6.12 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 8 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | Not disclosed Strike: $5.87 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 7 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires 2029-06-22 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.48 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 6 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.23 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 5 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.48 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 4 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.23 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 3 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.48 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 2 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 19:11 UTC | KAMADA LTD KMDA · Entity 5493 | GrantEmployee Stock Option (right to buy) · Derivative | 6,625 | Not disclosed Strike: $7.23 | Not disclosed |
DisclosureSEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 1 RECANATI LEON · CIK 0000919590 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trustee Disclosed balance after: 6,625 Underlying: Ordinary Shares · 6,625 shares Expires 2026-09-25 F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.